Pharma Meerhout
ActivePharma Meerhout has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €102k and a net result of €15k. Equity is shrinking by ~16.5% per year across the filed fiscal years. Its solvency ranks better than 24% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.7% (low).
Checked score
Score 2024
56
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability72▲+1
Solvency42▲+4
Growth58▲+26
Track record100
Bankruptcy probability, 12 months
0.7%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days only on tighter terms
Liquidity short (current ratio 0.9 against 0.86 in 2023; short-term debt: 60% and cash: 9% of total assets), and 83.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
16.7%
Return on assets
2.5%
Age of the figures
21 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 9623 sector peers (2024).
NBB · sector comparisonPosition among 9623 sector peers
Solvency
better than 24%
← weakest
strongest →
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 25-11-2025, 117 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
117 d late
2023
27 d late
2022
31 d late
2021
290 d late
2020
40 d late
2019
135 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€102k▲ 16.3%
2023 · €88k
2018: €302k
2019: €319k
2020: €227k
2021: €258k
2022: €327k
2023: €88k
2018 → 2024
Total assets
€612k▼ 8.3%
2023 · €667k
2018: €733k
2019: €691k
2020: €997k
2021: €987k
2022: €957k
2023: €667k
2018 → 2024
Net result
€15k▲ 24.4%
2023 · €12k
2018: €13k
2019: €17k
2020: €-92k
2021: €31k
2022: €71k
2023: €12k
2018 → 2024
Working capital
€-37k▲ 36.6%
2023 · €-59k
2018: €-843
2019: €220k
2020: €69k
2021: €95k
2022: €172k
2023: €-59k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€227k-€258k▲ 13.9%€327k▲ 26.5%€88k▼ 73.1%€102k▲ 16.3%
Operating result€-72k-€69k€83k▲ 20.5%€23k▼ 72.0%€23k▼ 1.2%
Net result€-92k-€31k€71k▲ 126%€12k▼ 82.5%€15k▲ 24.4%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2024 is 1% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €612k
Fixed assets
€282k▼ 10.2%
Current assets
€330k▼ 6.6%
Equity and liabilities €612k
Equity
€102k▲ 16.3%
Provisions
€3k▼ 11.8%
Debt
€507k▼ 12.0%
The debt ratio falls from 86.3% to 82.8%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€55k▼
2023 · €56k
Cash flow
€47k▲
2023 · €45k
Solvency
16.7%▲
2023 · 13.2%
Current ratio
0.90▲
2023 · 0.86
Quick ratio
0.49▼
2023 · 0.50
Debt / equity
4.95▼
2023 · 6.55
ROE
15.1%▲
2023 · 14.1%
ROA
2.5%▲
2023 · 1.9%
Interest coverage
6.07▼
2023 · 7.08
Debt
€507k▼
2023 · €576k
Debt ≤ 1 year
€367k▼
2023 · €412k
Debt > 1 year
€140k▼
2023 · €164k
Income taxes
€6k▲
2023 · €5k
Staff costs
€77k▲
2023 · €58k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€667k€612k▼
Fixed assets21/28€314k€282k▼
Tangible fixed assets22/27€314k€282k▼
Land and buildings22€311k€280k▼
Plant, machinery and equipment23€3k€2k▼
Current assets29/58€353k€330k▼
Stocks and contracts in progress3€149k€149k▲
Stocks30/36€149k€149k▲
Amounts receivable within one year40/41€35k€27k▼
Trade receivables40€35k€22k▼
Other amounts receivable41-€4k
Current investments50/53€35€35=
Cash at bank and in hand54/58€90k€55k▼
Deferred charges and accrued income490/1€79k€99k▲
Equity and liabilities
Total equity and liabilities10/49€667k€612k▼
Equity10/15€88k€102k▲
Contributions10/11€19k€19k=
Reserves13€47k€46k▼
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Tax-exempt reserves132€45k€44k▼
Profit (loss) carried forward14€22k€38k▲
Provisions and deferred taxes16€3k€3k▼
Deferred taxes168€3k€3k▼
Amounts payable17/49€576k€507k▼
Amounts payable after more than one year17€164k€140k▼
Financial debts170/4€164k€140k▼
Amounts payable within one year42/48€412k€367k▼
Current portion of amounts payable after more than one year42€24k€24k▲
Trade debts44€269k€272k▲
Suppliers440/4€269k€272k▲
Taxes, remuneration and social security45€9k€6k▼
Taxes450/3€9k€6k▼
Remuneration and social security454/9€119€313▲
Other amounts payable47/48€110k€64k▼
Income statement
Code20232024
Remuneration, social security and pensions62€58k€77k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€33k€32k▼
Other operating charges640/8€3k€3k▼
Gross operating margin9900€117k€135k▲
Operating profit (loss)9901€23k€23k▼
Financial income75/76B€423€6k▲
Recurring financial income75€423€6k▲
Financial charges65/66B€8k€9k▲
Recurring financial charges65€8k€9k▲
Profit (loss) for the period before taxes9903€16k€20k▲
Transfer from deferred taxes780€2k€2k=
Income taxes67/77€5k€6k▲
Profit (loss) for the period9904€12k€15k▲
Profit (loss) for the period to be appropriated9905€12k€15k▲
Appropriation of the result
Profit (loss) to be appropriated9906€272k€38k▼
Profit (loss) brought forward from the previous period14P€260k€22k▼
Profit to be distributed694/7€250k-
Return on contributions (dividend)694€250k-
Social balance
Average headcount (FTE)90871.01.0=
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
25-11
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 117 days late
2024
31-12
Financial
Equity above €100kEq €102k ▲16.3%
4 profitable years in a row build equity to €102k.
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 27 days late
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 31 days late
17-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 290 days late
2022
31-12
Financial
Highest result since 2018net €71k ▲126%
Operating result €83k, net result €71k, both a record.
2021
31-12
Financial
Back to profitnet €31k
Net result €31k after one loss-making year.
09-09
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 40 days late
2020
31-12
Financial
Weakest financial yearnet €-92k ▼652%
Net result drops to €-92k, the lowest in the series; recovery starts the following year.
13-12
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 135 days late
2019
01-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 32 days late
2018
24-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 24 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 31 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2011
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
25-03-2011
Medivita Management NV: Resigned as Manager
25-03-2011
Medivita Participations NV: Resigned as Manager
Location & real-estate footprint
Registered office, Meerhout · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Veldstraat 212450 MeerhoutGround area
177 m²
Building footprint
309 m²
Volume, LiDAR
2,824 m³
Parcel 13021B1314/00D000, Flanders · tallest building 14.7 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK SMANS BVBA
since 20032.126.463.593
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13021B1314/00D000 | Flanders | 177 m² | 1 · 309 m² | 14.7 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE LEPIECE
BE 0870.964.087
Chaudfontaine · Eq €102k
APOTEEK HANCOUR
BE 0404.302.136
Mortsel · Eq €102k
APOTHEEK MEES ZOLDER
BE 0454.292.273
Heusden-Zolder · Eq €102k
APOTEEK BRICHAU
BE 0439.520.559
Halle · Eq €102k
PharmaConseil
BE 0826.485.134
Verviers · Eq €102k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,424 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded31-01-2003
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.